OTC:SMNR | Income Statement | Semnur Pharmaceuticals, Inc.

Complete source-backed income-statement history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$1.25M$4.22M-$4.22M-$123,000.00-$4.35M-$0.02-$0.02230,209,142230,209,142
2026-03-31$1.27M$4.58M-$4.58M-$4.58M-$0.02-$0.02230,209,142230,209,142
2025-12-31$714,000.00$6.16M-$6.16M-$6.16M-$0.01-$0.014,216,2324,216,232
2025-09-30$1.14M$152.59M-$152.59M-$152.59M-$0.76-$0.76201,686,617201,686,617
2025-06-30$502,000.00$999,000.00-$999,000.00$0.00-$999,000.00-$0.01-$0.01200,000,000200,000,000
2025-03-31$187,000.00$665,000.00-$665,000.00-$665,000.00-$0.01-$0.01200,000,000200,000,000
2024-12-31$235,000.00$776,000.00-$776,000.00-$776,000.00$0.00$0.0000
2024-09-30$233,000.00$1.3M-$1.3M-$1.3M-$0.01-$0.01200,000,000200,000,000
2024-06-30-$168,186.00-$1.11M
2024-03-31-$368,252.00-$1.51M
2023-12-31-$182,482.00$553,343.00
2023-09-30-$505,895.00$630,586.00
2023-06-30-$563,701.00$457,709.00
2023-03-31-$1.01M
2022-12-31-$684,668.00
2022-09-30$307,468.00
2022-06-30-$30,847.00
2022-03-31-$11,343.001,242,733

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.55M$160.42M-$160.42M$0.00$0.00-$160.42M-$0.78-$0.78204,784,615204,784,615
2024-12-31$1.71M$4.69M-$4.69M$0.00$0.00-$4.69M-$0.02-$0.02200,000,000200,000,000
2023-12-31-$3.17M$632,536.00
2022-12-31-$419,390.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.